Behavioral consequences of bone marrow transplantation in the treatment of murine mucopolysaccharidosis type VII.
about
Systemic and central nervous system correction of lysosomal storage in mucopolysaccharidosis type VII miceFunctional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors.VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients.Active site mutant transgene confers tolerance to human beta-glucuronidase without affecting the phenotype of MPS VII mice.Production of MPS VII mouse (Gus(tm(hE540A x mE536A)Sly)) doubly tolerant to human and mouse beta-glucuronidaseNeonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better?Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation.Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function.Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice.Improved C3-4 transfer for treatment of root avulsion of the brachial plexus upper trunk: Animal experiments and clinical application.Brain transplantation of genetically modified bone marrow stromal cells corrects CNS pathology and cognitive function in MPS VII mice.Sulfamidase deficiency in a family of Dachshunds: a canine model of mucopolysaccharidosis IIIA (Sanfilippo A).
P2860
Q33645370-A8AFFC6B-6D13-4ED7-8277-99567AF12251Q34028579-23EEEAFA-9F67-477D-A870-FDA6ACD913C2Q34154821-6E7B01C3-9E68-4D77-AC05-F9C320B09FE1Q34446285-4DB78C72-EA1F-419B-AB9A-EE7F7300B896Q35032587-AB481080-CFEF-4D61-873E-3245355FD030Q36582259-87466319-1A59-4DDD-AA6A-466FCE546772Q37365631-4BCC0BB8-5480-49C6-93E1-52D1CBB85303Q37380187-ABFEA23B-84D0-47D5-9D4E-1ABAE05FD10BQ37381416-3980C5EA-6049-4DBB-9F10-7D831F865D25Q42103144-29BA1453-A272-4A54-A9FC-2DF682A5521CQ45877065-D4597262-CFCB-4792-8F0A-B3FAF9EF139CQ48429591-096359ED-C9A9-49E4-BC0D-DE8117A4B377
P2860
Behavioral consequences of bone marrow transplantation in the treatment of murine mucopolysaccharidosis type VII.
description
1994 nî lūn-bûn
@nan
1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Behavioral consequences of bon ...... ucopolysaccharidosis type VII.
@ast
Behavioral consequences of bon ...... ucopolysaccharidosis type VII.
@en
Behavioral consequences of bon ...... ucopolysaccharidosis type VII.
@nl
type
label
Behavioral consequences of bon ...... ucopolysaccharidosis type VII.
@ast
Behavioral consequences of bon ...... ucopolysaccharidosis type VII.
@en
Behavioral consequences of bon ...... ucopolysaccharidosis type VII.
@nl
prefLabel
Behavioral consequences of bon ...... ucopolysaccharidosis type VII.
@ast
Behavioral consequences of bon ...... ucopolysaccharidosis type VII.
@en
Behavioral consequences of bon ...... ucopolysaccharidosis type VII.
@nl
P2093
P2860
P356
P1476
Behavioral consequences of bon ...... mucopolysaccharidosis type VII
@en
P2093
D T Lambert
E Birkenmeier
P2860
P304
P356
10.1172/JCI117434
P407
P50
P577
1994-09-01T00:00:00Z